CarsonAllaria Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.6K | Buy |
132
+1
| +0.8% | +$186 | 0.01% | 180 |
|
|
2025
Q1 | $27.5K | Buy |
131
+1
| +0.8% | +$210 | 0.02% | 171 |
|
|
2024
Q4 | $23.1K | Buy |
130
+1
| +0.8% | +$178 | 0.01% | 187 |
|
|
2024
Q3 | $25.7K | Buy |
129
+1
| +0.8% | +$199 | 0.01% | 186 |
|
|
2024
Q2 | $22.1K | Buy |
128
+1
| +0.8% | +$173 | 0.01% | 188 |
|
|
2024
Q1 | $23.2K | Buy |
127
+1
| +0.8% | +$183 | 0.01% | 183 |
|
|
2023
Q4 | $19.6K | Buy |
126
+1
| +0.8% | +$156 | 0.01% | 172 |
|
|
2023
Q3 | $18.7K | Buy |
125
+1
| +0.8% | +$149 | 0.02% | 167 |
|
|
2023
Q2 | $16.7K | Buy |
124
+2
| +2% | +$270 | 0.01% | 183 |
|
|
2023
Q1 | $19.6K | Buy |
122
+1
| +0.8% | +$160 | 0.02% | 169 |
|
|
2022
Q4 | $20K | Buy |
121
+1
| +0.8% | +$165 | 0.02% | 151 |
|
|
2022
Q3 | $16K | Buy |
120
+1
| +0.8% | +$133 | 0.01% | 156 |
|
|
2022
Q2 | $18K | Sell |
119
-2
| -2% | -$303 | 0.02% | 150 |
|
|
2022
Q1 | $20K | Sell |
121
-42
| -26% | -$6.94K | 0.02% | 160 |
|
|
2021
Q4 | $22K | Buy |
+163
| New | +$22K | 0.02% | 168 |
|